Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer with PSA Screening By Ogkologos - November 4, 2025 26 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ERSPC study Source RELATED ARTICLESMORE FROM AUTHOR Rucaparib Monotherapy Provides Significant and Durable Long-Term Benefit as First-Line Maintenance for Patients with Advanced Ovarian Cancer with and without HRD FDA Approves Belantamab Mafodotin-blmf for Relapsed or Refractory Multiple Myeloma Long-Term Follow-Up Data Support Longer RFS with Adjuvant Nivolumab Than with Ipilimumab in Patients with Melanoma at High Risk for Recurrence MOST POPULAR Stage IV Cancer Patient Clinging to Life Overseas While Family Raises... May 28, 2020 The Most Successful Female Singer Of The 1970s Disappeared. Now She’s... May 1, 2019 GreaterGood Is Helping UMN Fight Social Injustice with Scholarship for Underrepresented... February 2, 2021 Study Shows Experimental Screening Test Can Detect Endometrial and Ovarian Cancers May 2, 2018 Load more HOT NEWS Cancer Clinical Trials Bounce Back After Significant COVID-19 Disruption: Data From... Exceptional Response to Single-Agent Anti-PD1 Therapy Observed in Patients with Advanced... FDA Grants Accelerated Approval to Infigratinib for Metastatic Cholangiocarcinoma Adding Pembrolizumab to Platinum-Based Chemotherapy Improves Survival in Patients with Previously...
